This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

5 Hated Stocks Poised to Pop on Earnings

From a technical perspective, DWA is currently trending below both its 50-day and 200-day moving averages, which is bearish. This stock has been trending sideways for the last three months, with shares moving between $15.90 on the downside and $18.32 on the upside. A high-volume move above the upper-end of its recent sideways chart pattern could trigger a breakout trade for shares of DWA post-earnings.

If you're bullish on DWA, then I would wait until after its report and look for long-biased trades if this stock manages to break out above some near-term overhead resistance levels at $17.69 to $18.32 a share with high volume. Look for volume on that move that hits near or above its three-month average action of 1.02 million shares. If that breakout triggers, then DWA will set up to re-test or possibly take out its next major overhead resistance levels at $19.82 to $22.98 a share.

I would avoid DWA or look for short-biased trades if after earnings it fails to trigger that breakout, and then drops back below some key near-term support and its 52-week low of $15.90 a share with high volume. If we get that move, then DWA will set up to enter new 52-week low territory, which is bearish technical price action. Some possible downside targets off that move are $14 to $13 a share.

Bio-Reference Laboratories

My final earnings short-squeeze trade idea is laboratory testing services player Bio-Reference Laboratories (BRLI - Get Report), which is set to release numbers on Thursday before the market open. Wall Street analysts, on average, expect Bio-Reference Laboratories to report revenue of $168.42 million on earnings of 28 cents per share.

If you're looking for a heavily-shorted stock that's been beaten-down notably heading into its earnings report this week, then make sure to check out shares of Bio-Reference Laboratories. This stock has been moving lower in 2013, with shares off by 10.9% so far.

The current short interest as a percentage of the float for Bio-Reference Laboratories is very high at 39.9%. That means that out of the 27.71 million shares in the tradable float, 9.53 million shares are sold short by the bears. If the bulls get the news they're looking for, then BRLI could easily rip higher post-earnings, since the float here is small and the short interest is huge.

6 of 7

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
MAKO $0.00 0.00%
BRLI $33.13 -1.70%
DECK $72.96 -2.10%
DWA $21.71 -1.50%
SHLD $38.99 -0.65%


DOW 17,869.47 -266.25 -1.47%
S&P 500 2,074.69 -26.35 -1.25%
NASDAQ 4,933.3860 -49.4230 -0.99%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs